Page last updated: 2024-09-03

imatinib mesylate and Hyperplasia, Reactive Lymphoid

imatinib mesylate has been researched along with Hyperplasia, Reactive Lymphoid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clément, JF; Contentin, N; Courville, P; Jardin, F; Laquerriere, A; Lehembre, S; Lenain, P; Lenormand, B; Pouplin, S; Tilly, H1

Other Studies

1 other study(ies) available for imatinib mesylate and Hyperplasia, Reactive Lymphoid

ArticleYear
Concomitant eosinophilia, fasciitis, and mycosis fungoides-like reaction with antinuclear autoantibodies in chronic myeloid leukaemia: role of a T-cell clone induced by imatinib.
    The Lancet. Oncology, 2005, Volume: 6, Issue:9

    Topics: Aged; Antibodies, Antinuclear; Antineoplastic Agents; Benzamides; Eosinophilia; Fasciitis; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mycosis Fungoides; Piperazines; Pseudolymphoma; Pyrimidines

2005